• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
FDA launches new priority review voucher program for select biopharmas

China

A colorful variation and collection of international currency a global business money exchange and finance
Biotech

US may be ending grants for biotechs with foreign investors

HHS is allegedly canceling clinical trial funding for biotechs with ties to certain foreign investors, Fierce Biotech has learned.
Gabrielle Masson Jun 18, 2025 11:50am
graphic image of China flags overlapping with US flags

China's rapid rise creates 'heightened risks' for pharma: PwC

Jun 18, 2025 5:00am
dynamic arrows moving up

US biotechs must adapt as global competition rises: Antares CEO

Jun 17, 2025 8:15am
China

China proposal would match US clinical trial review times

Jun 16, 2025 5:30pm
AstraZeneca

AstraZeneca pens $5.3B pact with CSPC to develop oral drugs

Jun 13, 2025 5:56am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Pfizer CEO makes case for $6B bet on 'fabulous' bispecific

Jun 10, 2025 9:56am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings